Dr. Yi Sun represents clients in patent and trade secret litigation, particularly in the biotechnology, pharmaceutical, and life sciences industries.
As a patent lawyer with a doctorate in molecular biology, Yi leverages her technical and legal experience in district court and appellate actions, including litigation arising under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act (BPCIA).
Yi advises clients at all stages of litigation, including pre-suit investigation, litigation, trial, and appeal.
Before joining Latham, Yi developed substantial experience in patent prosecution, patent portfolio management, opinion practice, and advising clients on freedom-to-operate and due diligence matters. She earned her PhD in molecular biology based on her research in genetic and cell-signaling control of embryonic development of the body axes. Her undergraduate thesis involved purification and characterization of recombinant proteins using chromatography.
Yi’s experience includes representing:
*Matter handled prior to joining Latham
Latham honored for a huge trade secrets win for LG Energy Solution at the US International Trade Commission, a significant patent trial victory for Astellas, and the strength of the firm's global Private Equity Practice.